Mankind Pharma, 543904, MANKIND Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,00,328.17
53.01
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,08,074.14
N/A
6.81

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
14.46
11.74

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
12.87
9.69

PAT CAGR (%)

10 Years
5 Years
3 Years

-
9.44
15.72

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

EV:EBITDA (Average)

8 Years
5 Years
3 Years

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 47.75 48.26 50.78 65.75
P/E Ratio 50.90 50.37 47.87 36.97
Revenue 10335 12207 14717 16537
EBITDA 2816 3555 3846 4472
Net Income 1913 1991 2106 2715
ROA 17.7 10 8.7 10.6
P/B Ratio 10.12 7.00 6.22 5.35
ROE 22.77 16.8 13.98 15.74
FCFF 1852 1913 2304 2872
FCFF Yield 1.7 1.76 2.11 2.63
Net Debt -3249 6266 -392 -146
BVPS 240.24 347.37 391.07 454.5

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 2,541.36 2,412.62 5.34% 2,126.59 2,007.47 5.93% 2,396.57 2,209.21 8.48% 2,529.74 2,260.47 11.91%
Expenses 1,868.29 1,836.58 1.73% 1,649.67 1,481.69 11.34% 1,655.64 1,636.04 1.20% 1,777.71 1,662.33 6.94%
EBITDA 673.07 576.04 16.84% 476.92 525.78 -9.29% 740.93 573.17 29.27% 752.03 598.14 25.73%
EBIDTM 26.48% 23.88% 22.43% 26.19% 30.92% 25.94% 29.73% 26.46%
Other Income 64.22 96.04 -33.13% 219.32 84.96 158.15% 69.82 67.24 3.84% 105.76 58.11 82.00%
Interest 146.70 6.63 2,112.67% 162.25 4.29 3,682.05% 199.47 4.26 4,582.39% 1.92 4.31 -55.45%
Depreciation 96.93 91.33 6.13% 105.24 86.62 21.50% 87.03 89.69 -2.97% 85.42 77.01 10.92%
PBT 493.66 574.12 -14.01% 428.75 519.83 -17.52% 524.25 546.46 -4.06% 770.45 574.93 34.01%
Tax 80.90 97.70 -17.20% 46.29 75.39 -38.60% 107.87 83.74 28.82% 168.01 128.14 31.11%
PAT 412.76 476.42 -13.36% 382.46 444.44 -13.95% 416.38 462.72 -10.01% 602.44 446.79 34.84%
PATM 16.24% 19.75% 17.98% 22.14% 17.37% 20.95% 23.81% 19.77%
EPS 10.00 11.54 -13.34% 9.27 10.77 -13.93% 10.09 11.21 -9.99% 14.60 10.83 34.81%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 3,570.35 2,867.85 24.50% 3,079.37 2,422.24 27.13% 3,230.00 2,606.95 23.90% 3,076.51 2,708.10 13.60%
Expenses 2,723.58 2,196.29 24.01% 2,396.18 1,835.94 30.52% 2,400.20 2,000.45 19.98% 2,226.47 2,025.45 9.92%
EBITDA 846.77 671.56 26.09% 683.19 586.30 16.53% 829.80 606.50 36.82% 850.04 682.65 24.52%
EBIDTM 23.72% 23.42% 22.19% 24.20% 25.69% 23.26% 27.63% 25.21%
Other Income 79.88 99.40 -19.64% 251.33 92.15 172.74% 77.32 70.13 10.25% 109.43 59.98 82.44%
Interest 170.65 10.84 1,474.26% 190.54 9.17 1,977.86% 220.93 9.19 2,304.03% 7.10 8.62 -17.63%
Depreciation 218.68 102.69 112.95% 230.87 99.78 131.38% 192.30 109.72 75.26% 105.62 96.49 9.46%
PBT 537.32 657.43 -18.27% 513.11 569.50 -9.90% 493.89 557.72 -11.44% 846.75 637.52 32.82%
Tax 95.87 122.86 -21.97% 86.44 94.99 -9.00% 112.81 102.51 10.05% 190.44 129.81 46.71%
PAT 441.45 534.57 -17.42% 426.67 474.51 -10.08% 381.08 455.21 -16.28% 656.31 507.71 29.27%
PATM 12.36% 18.64% 13.86% 19.59% 11.80% 17.46% 21.33% 18.75%
EPS 10.62 13.39 -20.69% 10.20 11.76 -13.27% 9.22 11.33 -18.62% 16.31 12.51 30.38%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 9,594.26 9,497.80 8,629.25 8,127.15 7,486.22 5,523.18 2,288.59 1,971.77 1,650.57 1,406.88 1,085.77 Net Sales Growth 7.92% 10.07% 6.18% 8.56% 35.54% 141.34% 16.07% 19.46% 17.32% 29.57% Cost Of Goods Sold 2,589.89 2,596.89 2,570.11 2,844.76 2,521.44 1,782.17 974.33 868.10 758.68 -109.37 495.66 Gross Profit 7,004.37 6,900.91 6,059.14 5,282.39 4,964.78 3,741.02 1,314.26 1,103.66 891.90 1,516.25 590.11 GP Margin 73.01% 72.66% 70.22% 65.00% 66.32% 67.73% 57.43% 55.97% 54.04% 107.77% 54.35% Total Expenditure 6,951.31 6,934.73 6,362.36 6,429.29 5,647.73 4,151.05 1,818.41 1,580.87 1,393.29 1,134.38 850.03 Power & Fuel Cost - 88.97 80.91 62.00 60.36 47.16 6.76 4.45 2.99 0.00 2.10 % Of Sales - 0.94% 0.94% 0.76% 0.81% 0.85% 0.30% 0.23% 0.18% 0% 0.19% Employee Cost - 2,131.67 1,921.09 1,701.38 1,462.76 1,167.42 354.31 299.05 237.02 0.00 139.94 % Of Sales - 22.44% 22.26% 20.93% 19.54% 21.14% 15.48% 15.17% 14.36% 0% 12.89% Manufacturing Exp. - 184.55 167.99 129.91 165.08 131.09 11.79 10.10 2.38 0.00 4.69 % Of Sales - 1.94% 1.95% 1.60% 2.21% 2.37% 0.52% 0.51% 0.14% 0% 0.43% General & Admin Exp. - 1,058.47 839.06 914.90 620.52 367.12 173.51 146.50 108.14 1,243.75 65.75 % Of Sales - 11.14% 9.72% 11.26% 8.29% 6.65% 7.58% 7.43% 6.55% 88.40% 6.06% Selling & Distn. Exp. - 731.09 657.51 607.88 686.50 482.85 168.11 237.69 272.55 0.00 139.71 % Of Sales - 7.70% 7.62% 7.48% 9.17% 8.74% 7.35% 12.05% 16.51% 0% 12.87% Miscellaneous Exp. - 143.09 125.69 168.47 131.08 173.25 129.61 14.98 11.52 0.00 139.71 % Of Sales - 1.51% 1.46% 2.07% 1.75% 3.14% 5.66% 0.76% 0.70% 0% 0.20% EBITDA 2,642.95 2,563.07 2,266.89 1,697.86 1,838.49 1,372.13 470.18 390.90 257.28 272.50 235.74 EBITDA Margin 27.55% 26.99% 26.27% 20.89% 24.56% 24.84% 20.54% 19.82% 15.59% 19.37% 21.71% Other Income 459.12 493.21 270.50 162.78 203.81 154.50 43.61 30.91 33.96 23.85 19.68 Interest 510.34 372.28 16.93 28.23 47.54 8.23 1.66 1.57 1.55 0.00 1.52 Depreciation 374.62 378.01 335.26 269.58 123.33 78.19 26.55 23.78 11.47 7.76 4.44 PBT 2,217.11 2,305.99 2,185.20 1,562.84 1,871.44 1,440.21 485.58 396.45 278.23 288.59 249.46 Tax 403.07 421.74 412.57 314.58 482.01 355.83 141.38 105.88 64.53 81.70 77.44 Tax Rate 18.18% 18.29% 18.88% 20.13% 25.76% 24.71% 29.12% 26.71% 23.19% 28.31% 31.04% PAT 1,814.04 1,884.25 1,772.63 1,248.26 1,389.42 1,084.37 344.20 290.57 213.69 206.89 172.02 PAT before Minority Interest 1,814.04 1,884.25 1,772.63 1,248.26 1,389.42 1,084.37 344.20 290.57 213.69 206.89 172.02 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 18.91% 19.84% 20.54% 15.36% 18.56% 19.63% 15.04% 14.74% 12.95% 14.71% 15.84% PAT Growth -0.89% 6.30% 42.01% -10.16% 28.13% 215.04% 18.46% 35.98% 3.29% 20.27% EPS 43.96 45.66 42.95 30.25 33.67 26.28 8.34 7.04 5.18 5.01 4.17

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Net Sales 12,956.23 12,207.44 10,260.44 8,749.43 7,781.56 6,214.43 Net Sales Growth 22.17% 18.98% 17.27% 12.44% 25.22% Cost Of Goods Sold 3,739.08 3,489.04 3,198.47 2,913.64 2,421.73 1,780.60 Gross Profit 9,217.15 8,718.40 7,061.97 5,835.79 5,359.83 4,433.82 GP Margin 71.14% 71.42% 68.83% 66.70% 68.88% 71.35% Total Expenditure 9,746.43 9,186.97 7,745.27 6,847.50 5,791.01 4,565.32 Power & Fuel Cost - 149.49 125.16 108.96 103.13 82.53 % Of Sales - 1.22% 1.22% 1.25% 1.33% 1.33% Employee Cost - 2,692.37 2,260.60 1,918.47 1,620.59 1,415.78 % Of Sales - 22.06% 22.03% 21.93% 20.83% 22.78% Manufacturing Exp. - 216.03 172.71 150.57 189.81 140.14 % Of Sales - 1.77% 1.68% 1.72% 2.44% 2.26% General & Admin Exp. - 1,314.02 939.49 1,000.80 626.47 451.75 % Of Sales - 10.76% 9.16% 11.44% 8.05% 7.27% Selling & Distn. Exp. - 1,164.71 924.26 638.11 708.17 587.73 % Of Sales - 9.54% 9.01% 7.29% 9.10% 9.46% Miscellaneous Exp. - 161.31 124.58 116.96 121.10 106.78 % Of Sales - 1.32% 1.21% 1.34% 1.56% 1.72% EBITDA 3,209.80 3,020.47 2,515.17 1,901.93 1,990.55 1,649.11 EBITDA Margin 24.77% 24.74% 24.51% 21.74% 25.58% 26.54% Other Income 517.96 536.79 280.22 128.57 196.03 170.95 Interest 589.22 431.95 34.24 45.76 59.80 21.16 Depreciation 747.47 621.22 378.42 325.92 166.62 118.97 PBT 2,391.07 2,504.09 2,382.73 1,658.81 1,960.15 1,679.93 Tax 485.56 509.74 457.15 361.56 521.64 398.58 Tax Rate 20.31% 20.36% 19.19% 21.80% 26.61% 23.73% PAT 1,905.51 1,986.43 1,911.92 1,281.86 1,433.48 1,265.42 PAT before Minority Interest 1,885.63 2,006.59 1,940.79 1,309.68 1,452.96 1,293.03 Minority Interest -19.88 -20.16 -28.87 -27.82 -19.48 -27.61 PAT Margin 14.71% 16.27% 18.63% 14.65% 18.42% 20.36% PAT Growth -3.37% 3.90% 49.15% -10.58% 13.28% EPS 46.17 48.13 46.33 31.06 34.73 30.66

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 14,640.27 9,702.77 7,783.91 6,540.45 4,734.27 1,555.50 1,211.29 920.72 706.73 499.84 Share Capital 41.26 40.06 40.06 40.06 40.06 20.03 20.03 20.03 20.03 14.84 Total Reserves 14,555.34 9,639.46 7,743.79 6,500.39 4,694.21 1,535.47 1,191.26 900.69 686.70 485.00 Non-Current Liabilities 5,096.53 197.06 168.12 126.98 54.11 31.36 29.46 28.49 25.41 5.78 Secured Loans 4,942.69 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.71 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 126.10 113.52 88.87 73.79 56.39 4.84 2.08 1.98 4.64 0.00 Current Liabilities 4,091.52 1,616.56 1,419.09 2,271.27 1,078.91 593.98 540.34 474.53 364.76 233.24 Trade Payables 563.62 524.99 801.96 921.29 594.08 175.79 149.57 203.89 157.88 99.49 Other Current Liabilities 852.65 657.34 279.51 399.57 196.75 108.74 65.19 51.51 46.95 54.77 Short Term Borrowings 2,123.00 14.93 0.00 683.66 95.00 0.03 0.00 0.00 0.80 0.00 Short Term Provisions 552.25 419.30 337.61 266.74 193.08 309.42 325.58 219.13 159.13 78.99 Total Liabilities 23,828.32 11,516.39 9,371.12 8,938.70 5,867.29 2,180.84 1,781.09 1,423.74 1,096.90 738.86 Net Block 3,470.75 3,546.28 3,136.89 2,921.30 981.95 202.69 202.56 177.72 74.60 84.62 Gross Block 4,845.33 4,572.75 3,770.10 3,286.82 1,221.61 286.14 259.54 210.98 96.68 99.12 Accumulated Depreciation 1,374.58 1,026.47 633.21 365.51 239.65 83.45 56.98 33.26 22.08 14.50 Non Current Assets 19,132.31 5,886.84 5,854.21 5,122.99 2,777.31 568.46 529.02 383.14 195.13 248.34 Capital Work in Progress 207.43 209.44 494.78 386.57 165.57 21.37 6.44 0.43 18.11 7.30 Non Current Investment 15,124.52 1,975.85 2,040.76 1,657.08 1,500.86 109.51 87.66 27.01 12.47 156.42 Long Term Loans & Adv. 182.22 142.85 148.86 146.30 115.59 218.84 167.59 110.92 39.79 0.00 Other Non Current Assets 147.39 7.14 27.58 6.37 7.88 16.05 64.77 67.05 50.16 0.00 Current Assets 4,693.31 5,626.85 3,513.72 3,813.01 3,089.98 1,612.38 1,252.07 1,040.60 901.76 490.52 Current Investments 1,558.86 2,239.51 1,061.47 868.79 896.03 689.05 350.46 149.15 247.22 0.00 Inventories 1,090.98 1,126.03 1,032.22 1,266.69 826.91 337.19 312.67 361.73 271.93 153.55 Sundry Debtors 894.67 769.04 492.64 470.59 369.17 131.59 112.41 141.39 113.40 93.30 Cash & Bank 305.87 483.88 155.15 138.85 476.95 99.96 104.51 89.15 83.41 99.55 Other Current Assets 842.93 90.95 59.05 166.44 520.92 354.59 372.02 299.18 185.81 144.12 Short Term Loans & Adv. 771.47 917.44 713.20 901.65 414.91 351.81 372.02 299.18 184.89 144.12 Net Current Assets 601.79 4,010.29 2,094.63 1,541.74 2,011.07 1,018.40 711.73 566.07 537.00 257.28 Total Assets 23,825.62 11,513.69 9,367.93 8,936.00 5,867.29 2,180.84 1,781.09 1,423.74 1,096.89 738.86

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Shareholder's Funds 14,332.39 9,363.09 7,435.22 6,155.23 4,722.00 Share Capital 41.26 40.06 40.06 40.06 40.06 Total Reserves 14,247.46 9,299.78 7,395.10 6,115.17 4,681.94 Non-Current Liabilities 7,419.90 187.34 199.24 168.68 107.33 Secured Loans 5,077.83 24.87 23.15 48.94 57.42 Unsecured Loans 448.36 0.00 0.00 0.25 0.25 Long Term Provisions 155.06 123.12 97.89 80.00 72.24 Current Liabilities 5,663.56 2,119.73 1,863.14 2,623.46 1,353.40 Trade Payables 1,133.40 777.06 1,008.18 1,076.40 666.97 Other Current Liabilities 1,335.07 755.50 386.05 472.89 282.77 Short Term Borrowings 2,513.14 151.48 115.02 794.59 158.35 Short Term Provisions 681.95 435.69 353.89 279.59 245.30 Total Liabilities 27,651.64 11,882.86 9,685.67 9,108.45 6,323.62 Net Block 19,004.48 4,539.95 4,245.28 3,582.77 1,658.94 Gross Block 20,916.96 5,909.74 5,233.03 4,246.54 2,160.04 Accumulated Depreciation 1,912.48 1,369.79 987.75 663.78 501.10 Non Current Assets 20,663.37 5,314.64 5,357.80 4,701.63 2,416.98 Capital Work in Progress 825.67 281.80 550.15 701.47 371.95 Non Current Investment 351.09 309.81 270.95 235.01 205.80 Long Term Loans & Adv. 293.08 163.97 187.54 163.88 158.07 Other Non Current Assets 189.00 13.79 98.51 13.09 16.72 Current Assets 6,985.57 6,565.52 4,324.56 4,403.84 3,906.64 Current Investments 1,690.84 2,258.11 1,075.47 874.46 1,306.17 Inventories 2,093.71 1,553.46 1,498.46 1,760.24 1,183.54 Sundry Debtors 1,538.34 848.28 576.42 388.17 330.61 Cash & Bank 554.50 708.10 453.20 405.94 700.74 Other Current Assets 1,108.18 104.10 64.29 170.74 385.57 Short Term Loans & Adv. 1,010.76 1,093.47 656.71 804.29 275.79 Net Current Assets 1,322.01 4,445.79 2,461.42 1,780.37 2,553.24 Total Assets 27,648.94 11,880.16 9,682.36 9,105.47 6,323.62

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 2,322.16 1,736.08 1,798.99 821.44 983.38 355.00 302.53 -12.85 76.28 134.50 PBT 2,390.36 2,325.72 1,562.84 1,871.44 1,440.21 485.58 396.45 278.23 288.59 249.46 Adjustment 339.35 164.74 227.00 -4.16 96.74 -15.62 -5.64 -21.00 -14.54 -13.65 Changes in Working Capital 63.93 -333.38 294.21 -585.61 -156.19 16.75 7.20 -185.29 -109.07 -16.87 Cash after chg. in Working capital 2,793.64 2,157.08 2,084.05 1,281.67 1,380.76 486.71 398.02 71.94 164.97 218.94 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -471.48 -421.00 -285.06 -460.22 -397.38 -131.71 -95.49 -84.79 -88.69 -84.44 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -12,114.68 -1,665.19 -1,040.61 -1,360.27 -1,127.16 -358.15 -285.77 20.74 -87.97 -84.29 Net Fixed Assets -270.57 -517.31 -591.49 -2,286.21 -1,079.67 -41.53 -54.57 -96.62 -8.37 -37.75 Net Investments -12,468.02 -1,113.13 -576.36 -128.98 -1,598.33 -360.44 -261.96 83.53 -103.27 -66.34 Others 623.91 -34.75 127.24 1,054.92 1,550.84 43.82 30.76 33.83 23.67 19.80 Cash from Financing Activity 9,845.34 -4.73 -710.41 578.63 88.87 -1.41 -1.40 -2.15 -4.46 -10.27 Net Cash Inflow / Outflow 52.82 66.16 47.96 39.81 -54.91 -4.55 15.36 5.74 -16.14 39.94 Opening Cash & Equivalents 211.62 145.46 86.17 46.36 77.50 104.51 89.15 83.41 99.55 59.61 Closing Cash & Equivalent 200.29 211.62 134.13 86.17 22.58 99.96 104.51 89.15 83.41 99.55

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Cash From Operating Activity 2,413.38 2,152.44 1,813.30 919.78 1,137.24 PBT 2,524.78 2,399.35 1,671.24 1,974.60 1,691.61 Adjustment 601.77 212.19 298.43 30.81 -5.66 Changes in Working Capital -146.42 -17.57 166.73 -586.12 -94.63 Cash after chg. in Working capital 2,980.13 2,593.97 2,136.40 1,419.29 1,591.32 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -566.75 -441.53 -323.10 -499.51 -454.07 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -12,682.95 -2,081.69 -1,054.13 -1,369.14 -1,222.21 Net Fixed Assets -270.57 -517.31 -591.49 -2,286.21 Net Investments -12,468.02 -1,113.13 -576.36 -128.98 Others 55.64 -451.25 113.72 1,046.05 Cash from Financing Activity 10,232.56 5.27 -739.73 604.62 -7.81 Net Cash Inflow / Outflow -37.01 76.02 19.44 155.26 -92.78 Opening Cash & Equivalents 382.01 304.82 283.06 127.33 219.73 Closing Cash & Equivalent 403.88 382.01 304.82 283.06 127.33

Financial Ratios

Standalone /

Consolidated

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 353.77 241.63 194.31 163.27 118.18 776.61 604.76 459.68 352.84 336.89 ROA 10.66% 16.97% 13.63% 18.77% 20.90% 17.38% 18.13% 16.96% 22.54% 27.45% ROE 15.52% 20.30% 17.43% 24.65% 25.86% 24.88% 27.26% 26.26% 34.29% 41.28% ROCE 17.05% 25.16% 21.20% 31.84% 34.16% 35.22% 37.34% 34.37% 47.66% 59.45% Fixed Asset Turnover 2.08 2.14 2.40 3.45 4.73 8.39 8.38 10.73 14.37 12.96 Receivable days 31.06 25.76 20.75 19.69 26.03 19.46 23.49 28.17 26.81 27.58 Inventory Days 41.38 44.06 49.52 49.10 44.95 51.82 62.42 70.06 55.19 45.41 Payable days 76.50 94.23 110.55 109.68 110.73 37.38 44.99 47.49 0.00 37.71 Cash Conversion Cycle -4.06 -24.41 -40.28 -40.89 -39.75 33.90 40.92 50.75 82.01 35.28 Total Debt/Equity 0.48 0.00 0.00 0.10 0.02 0.00 0.00 0.00 0.00 0.01 Interest Cover 7.19 130.07 56.36 40.37 175.93 294.17 253.23 180.56 0.00 165.50

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Book Value (Rs.) 346.31 233.15 185.61 153.65 117.88 ROA 10.15% 18.00% 13.94% 18.83% 22.79% ROE 16.98% 23.14% 19.27% 26.72% 31.51% ROCE 18.32% 28.35% 23.49% 33.96% 39.97% Fixed Asset Turnover 0.95 1.92 1.92 2.52 3.00 Receivable days 34.35 24.35 19.33 16.25 25.31 Inventory Days 52.50 52.16 65.31 66.57 61.16 Payable days 99.93 101.86 130.57 131.38 144.73 Cash Conversion Cycle -13.08 -25.35 -45.92 -48.56 -58.26 Total Debt/Equity 0.58 0.02 0.02 0.14 0.05 Interest Cover 6.83 71.03 37.52 34.02 80.96

Top Investors:

government pension fund global

nps trust a/c - sbi pension fund - ups - cg scheme

sbi healthcare opportunities fund

axis mutual fund trustee limited a/c axis mutual fund

sbi life insurance co. ltd.

Annual Reports:

News Update:

Mankind Pharma gets ESG score of 38.98 from ISS ESG
5th Jun 2025, 10:30 AM

The company has not verified any data on which this rating has been issued
Read More
Mankind Pharma reports 11% fall in Q4 consolidated net profit
22nd May 2025, 12:30 PM

The total consolidated income of the company increased by 32.47% at Rs 3,330.70 crore for Q4FY25
Read More
Mankind Pharma gets nod to incorporate wholly owned subsidiary in Sri Lanka
22nd May 2025, 11:09 AM

The Board of Directors of the Company at its meeting held on May 21, 2025, has approved the same
Read More

Mankind Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543904 | NSE: MANKIND

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

Mankind Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543904 | NSE: MANKIND

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: